Dawn Lee is Chief Scientific Officer at BresMed.
Dawn is a passionate supporter of the move to more integrated statistical and health economic
analyses and the use of appropriate software, such as R, to achieve this. She has experience in
a number of disease areas and project types, and currently specializes in oncology modelling
(in immuno-oncology in particular), early product assessment, health technology assessment
(HTA) strategy, complex decision problems, models with complex statistical needs, end-to-end
modelling solutions using
R-Shiny and anything else “a bit weird and wonderful”. She is the
originator of BresMed’s intRface™ a product created in
R which integrates statistical analysis
with a modeling framework to enable user- friendly, transparent and real-time investigation of
Her role as Chief Scientific Officer focuses on achieving and maintaining BresMed’s position at the leading edge of health economics and outcomes research, identifying trends within the industry and new types of work and methods for BresMed.